Form 4 for EW Edwards Lifesciences
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-14 · accession 0001225208-23-001936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $35.20 | +29.4K | 186.7K | +19% | +$1.03M |
| DM | 2023-02-14 | 2023-02-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $77.00 | -19.9K | 157.4K | -11% | -$1.53M |
| D | 2023-02-14 | 2023-02-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -9,500 | 173.6K | -5% | $0 |
| DI | 2023-02-14 | 2023-02-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +9,500 | 3.49M | +0.3% | $0 |
| D | 2023-02-14 | 2023-02-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -29.4K | 88.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 29,375 | $35.20 | 186,727.82 | D By Living Trust | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | S | D | 3,600 | $77.75 | 183,127.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $77.285 to $78.110 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-02-14 | G | D | 9,500 | $0.00 | 173,627.82 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | S | D | 16,275 | $76.83 | 157,352.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $76.280 to $77.280 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-02-14 | G | A | 9,500 | $0.00 | 3,492,017 | I | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Acquire) | 2023-02-14 | M | D | 29,375 | $0.00 | 88,125 | D | $35.20 · 2016-06-12 to 2023-05-11 | 29,375 Common Stock |